Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients
Clinical trial NCT03091673 · COMPLETED
Trial details
- NCT number
- NCT03091673
- Sponsor
- Xeris Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-27
- Primary completion
- 2017-09-07
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.